Jonathan Lim: Which ASCO26 and ESMO26 Findings Could Change Clinical Practice?
Jonathan Lim/LinkedIn

Jonathan Lim: Which ASCO26 and ESMO26 Findings Could Change Clinical Practice?

Jonathan Lim, Associate Faculty at Cancer Research UK Manchester Institute, shared on LinkedIn:

“Just a few tickets left!

Missed ASCO26 or ESMO26 – or keen to make sense of the latest data?

Join us next Friday 13 November (1 pm onwards) for The Christie ESMO ASCO Highlights, with our experts’ perspectives on practice-changing studies and what they mean for patient care.

𝘍𝘢𝘤𝘶𝘭𝘵𝘺:
Rachel Woodford, Kalena Martí, Jonathan Lim, Dr Caroline Wilson, Jamie Weaver, Alkistis Papatheodoridi, Nadina Tinsley, Maria João Serra, Fiona Britton, Helen Adderley, Daniel Netto.

We’d love to see you there!
Book your place.”

Other articles about Jonathan Lim on OncoDaily.